ArticleCardiovascular diabetology2025
Association of epicardial fat volume index with coronary artery disease phenotypes based on anatomical and functional imaging: a linkage with the severity of coronary artery disease.
Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic impact of epicardial fat volume, anatomical and functional imaging across the cardiovascular risk spectrum in patients with suspected coronary artery disease: a single-center retrospective cohort study.Quantitative imaging in medicine and surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundEpicardial adipose tissue (EAT) plays an important role in the pathogenesis of coronary artery disease (CAD). The association between EAT and obstructive CAD or myocardial ischemia has been established, but its relationship with CAD phenotypes based on anatomical and functional imaging remains unclear.
methodsA total of 495 suspected CAD patients who underwent both single-photon emission computed tomography/computed tomography myocardial perfusion imaging (SPECT/CT MPI) and coronary angiography (CAG/CTA) were enrolled in this retrospective study. Epicardial fat volume (EFV) and epicardial fat volume indexed to body surface (EFVi) were measured on non-contrast CT. CAD phenotypes were categorized into 4 groups based on the presence or absence of obstructive CAD (any epicardial coronary diameter stenosis ≥ 50% by CAG/CTA) and myocardial ischemia (diagnosed by MPI): Group1 (non-obstructive CAD without ischemia, n = 165), Group2 (ischemia with non-obstructive CAD, INOCA, n = 69), Group3 (obstructive CAD without ischemia, n = 149), Group4 (obstructive CAD with ischemia, n = 112).
resultsBoth EFV and EFVi had an increasing trend across 4 groups [EFVi: median (interquartile range), cm
conclusionEFVi was correlated with the severity of CAD phenotype levels based on anatomical and functional imaging. EFVi had the strongest correlation with CAD phenotypes levels in diabetes subgroup. Notably, EFVi rather than EFV exhibits a distinct linkage with INOCA. EFVi was more effective to provide incremental value of differentiating CAD phenotypes over traditional cardiovascular risk factors than EFV in diabetes subgroup.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.